计算溶液所需的质量、体积或浓度。
提供 ≥99% 纯度,适用于对基线干扰要求严格的色谱和分析工作流程。
2-8°C储存,干燥。低温运输 。请查阅批次 COA 获取详细规格。
SDS、COA、产品数据表及规格说明书均可下载。可通过批号查询获取批次 COA。
在色谱分析、有机合成和交叉偶联反应领域已被 0 篇同行评审文献引用。
Asciminib (ABL001) hydrochloride is a potent and selective allosteric BCR-ABL1 inhibitor, which inhibits Ba/F3 cells grown with an IC 50 of 0.25 nM.
In Vitro
Asciminib (ABL001) hydrochloride binds to the myristoyl pocket of ABL1 and induces the formation of an inactive kinase conformation. Asciminib hydrochloride binds potently (dissociation constant=0.5-0.8 nM) and selectively to the myristoyl pocket of ABL1 and induces the inactive C-terminal helix conformation. Asciminib hydrochloride exhibits the same non-ATP-competitive biochemical kinetics as the BCR–ABL inhibitor GNF-2 but with approximately 100-fold greater potency. Asciminib hydrochloride lacks activity against more than 60 kinases, including SRC, and is similarly inactive against G-protein-coupled receptors, ion channels, nuclear receptors and transporters. In BCR–ABL1-transformed Ba/F3 cells grown without IL-3, Asciminib hydrochloride has an anti-proliferative with IC 50 value of 0.25 nM. In the CML blast-phase cell line KCL-22, Asciminib hydrochloride inhibits phosphorylation of both STAT5 (Tyr694; pSTAT5) and BCR–ABL1 (Tyr245; pBCR–ABL1) after 1 h using concentrations that correlate with those required for inhibition of cell proliferation. Asciminib hydrochloride is selectively active against all BCR–ABL1 lines (IC 50 value of 1–20 nM), irrespective of the presence of either the p210 or the p190 BCR–ABL1 isoform. MCE has not independently confirmed the accuracy of these methods. They are for reference only.
In Vivo
Single doses of 7.5, 15 and 30 mg/kg Asciminib, administered to mice bearing KCL- 22 xenografts, inhibits pSTAT5 (Tyr694), which return to baseline at 10, 12 and 16-20 h after administration of the dose, respectively. In mice implanted with KCL-22 tumors, the minimum dose of Asciminib required for complete regression is 7.5 mg/kg twice a day (BID) or 30 mg/kg once a day (QD), and is tolerated at doses up to 250 mg/kg BID . MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Form:Solid
分类树(Taxonomy Tree)
| 界(kingdom) | 有机化合物 |
|---|---|
| 超类(Superclass) | 苯类化合物 |
| 类(Class) | 苯及其取代衍生物 |
| 亚类(Subclass) | 苯胺类 |
| 中间层级节点(Intermediate Tree Nodes) | 暂无 |
| 直接上位类(Direct Parent) | 芳香族苯胺 |
| 其他上位类(Alternative Parents) | 吡唑基吡啶 烟酰胺 多卤吡啶 苯氧基化合物 酚醚 二烷基芳胺 羟基吡啶 氨基吡啶及其衍生物 2-卤代吡啶 咪唑内酰胺类 吡咯烷 吡唑类 杂芳族化合物 1,3-氨基醇 三卤甲烷 仲醇 氨基酸及其衍生物 羧酸酰胺 氮杂环化合物 有机光子化合物 有机氟化物 有机氯化物 有机氧化物 盐酸盐 碳氢化合物衍生物 烷基氟化物 烷基氯 |
| 分子骨架(Molecular Framework) | 芳香族杂单环化合物 |
| 取代基(Substituents) | 1,3-氨基醇 - 2-卤代吡啶 - 3-吡唑基吡啶 - 羟基苯甲酸酯 - 氟化烷基 - 氟化烷基 - 烷基溴化物 - 氨基酸 - 氨基酸或其衍生物 - 氨基吡啶 - 芳香族苯胺 - 芳香族杂单环化合物 - 氮杂环 - 吡唑 - 羧酰胺基 - 羧酸衍生物 - 二烷基芳基胺 - 卤甲烷 - 杂芳香族化合物 - 烃衍生物 - 氟氯烃 - 羟基吡啶 - 咪唑内酰胺 - 烟酰胺 - 有机硝基化合物 - 有机氧化物 - 有机氧化合物 - 有机氯化物 - 有机氟化物 - 有机卤化物 - 有机杂环化合物 - 有机氮化合物 - 有机氧化合物 - 有机氮化合物 - 苯酚醚 - 苯氧基化合物 - 多卤代吡啶 - 吡唑 - 吡啶 - 吡啶羧酸或其衍生物 - 吡咯烷 - 醛基 - 三级脂肪族/芳香族胺 - 三芳基胺 - 三卤甲烷 |
| 描述(Description) | 该化合物属于芳香族苯胺类有机化合物。这类芳香化合物含有苯胺基团,其中羧酰胺基被芳香基团取代。其通式为RNC(=O)R',其中R=苯基,R=芳香族基团。 |
| 外部描述符(External Descriptors) | 暂无 |
H317: 可能引起皮肤过敏反应
H360D: 可能会伤害未出生的孩子
H373: 通过长时间或反复暴露对器官造成损害